JK
Elite in Metastatic Brain Tumor
Check Dr. John P. Kirkpatrick's experience treating your condition:
About Dr. John P. Kirkpatrick

John Kirkpatrick is a Radiation Oncologist in Raleigh, North Carolina. Kirkpatrick has been practicing medicine for over 23 years and is rated as an Elite expert by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 41 other conditions, according to our data. His top areas of expertise are Brain Tumor, Metastatic Brain Tumor, Meningioma, Glioma, and Gamma Knife Radiosurgery. He is licensed to treat patients in North Carolina. Kirkpatrick is currently accepting new patients.

His clinical research consists of co-authoring 134 peer reviewed articles and participating in 7 clinical trials in the past 15 years. In particular, he has co-authored 10 articles and participated in 2 clinical trials in the study of Metastatic Brain Tumor.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. John P. Kirkpatrick it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
3404 Wake Forest Rd, Raleigh, NC 27609
Background & Education
Graduate Institution
Other, 1999
Specialties
Radiation Oncology
Licenses
Radiology in NC
Hospital Affiliations
Maria Parham Medical Center
Duke Regional Hospital
Sovah Health - Danville
Duke University Hospital
Duke Raleigh Hospital
Languages Spoken
English
French
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Phase II Single-arm Study of Post-operative Stereotactic Radiosurgery for Brain Metastases.
Phase I/II Trial Evaluating Toxicity and Efficacy of Adding Stereotactic Body Radiotherapy to Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer
Radiosurgery and Avastin for Recurrent Malignant Gliomas
Determination of the Optimal Planning Target Volume for Brain Metastases Treated With Stereotactic Radiosurgery
Phase II Single-arm Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases.
View 6 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Distinguished
Distinguished
Distinguished